Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, has unveiled a new initiative aimed at improving outcomes for patients with life-threatening heart rhythm disorders.

The Collaborative Outcomes Registry for Evidence in Ventricular Arrhythmias (CORE-VA) was introduced during the International Symposium on Ventricular Arrhythmias in Philadelphia, Pennsylvania.

The prospective, multicenter registry is designed to capture contemporary practice patterns in ventricular arrhythmia, including ventricular tachycardia (VT), ablation and generate high-quality real-world evidence.

“Real-world standard-of-care registries are essential for refining techniques, guiding training and expanding patient access. CORE-VA could illuminate how we can simplify procedures, further identify and avoid risks, and improve access and outcomes for ventricular arrhythmia patients,” said Francis E. Marchlinski, Director of Electrophysiology, University of Pennsylvania Health Care System, and CORE-VA Steering Committee Co-Chair.

Ventricular tachycardia, a rapid heart rhythm originating in the heart’s lower chambers, is a major cause of sudden cardiac death. Given the complexity of VT ablation, the procedure is typically performed by highly skilled electrophysiologists with advanced treatment strategies. CORE-VA aims to become the largest data repository of ventricular mapping and ablation workflows, technologies and patient outcomes.

Jennifer Currin, Vice President, Scientific Affairs, Electrophysiology, Johnson & Johnson MedTech, emphasised, “CORE-VA is another example of Johnson & Johnson’s commitment to building rigorous clinical and scientific evidence that shapes the future of arrhythmia care.”

“As new technologies are introduced and adopted into clinical practice, this registry will enable us to rapidly collect and analyze real-world data, helping to benchmark outcomes against existing technologies and guide best practices. The insights gained through this collaborative effort have the potential to inform clinical standards, training initiatives and future advancements in this complex arrythmia field," she added.